Citation: Shi-meng ZHANG, Rong FAN, Tian-yi YANG, Yi1 SUN, Jing-yun LI, Qin-zhi XU, Ping-kun ZHOU. An Improved Strategy for Efficient Expression and Purification of Soluble HIV-1 Tat Protein in E.coli .VIROLOGICA SINICA, 2009, 24(6) : 518-528.  http://dx.doi.org/10.1007/s12250-009-3068-6

An Improved Strategy for Efficient Expression and Purification of Soluble HIV-1 Tat Protein in E.coli

cstr: 32224.14.s12250-009-3068-6
  • Corresponding author: Ping-kun ZHOU, zhoupk@nic.bmi.ac.cn
  • Received Date: 05 May 2009
    Accepted Date: 16 August 2009
    Available online: 01 December 2009

    Fund Project: a grant from the International Atomic Energy Agency (IAEA) 12510/R1a grant from the Chinese NationalNatural Science Foundation 30400120

  • Although the endogenous function of Tat has been elucidated in the past twenty years, the study of its exogenous activity has been hampered due to the difficulty of large scale preparation of the active Tat protein. To express the full-length Tat protein in E.coli, the tat gene was cloned from an HIV infected patient by overlapping PCR. Rare codon usage analysis showed that rare E.coli codons, especially consecutive rare codons for Arg, account for 14% (14 of 101) rare E.coli codons in the tat gene. The expression of the HIV-1 tat gene was verified to be very poor in strain BL21 (DE3) due to the abundance of rare codons; however, tat gene expression was found to be very efficient in the host strain of Rosetta-gami B (DE3), which was supplemented with six rare tRNAs for Arg, Leu, Ile and Pro. Subsequent purification revealed that the proteins are soluble and unusually, the tagged Tat can form dimers independent of cystine disulfide bonds. The purity, integrity and molecular weight of the Tat protein were demonstrated by MALDI-TOF mass spectrometry. Reporter gene activating assay was further confirmed by investigating the transactivation activity of the recombinant Tat protein. Our improved strategy for efficient high level expression and purification of soluble Tat protein has paved the way to fully investigate its exogenous function.

  • 加载中
    1. Barboric M, Peterlin B M. 2005, A new paradigm in eukaryotic biology, HIV Tat and the Control of Transcriptional Elongation. PLoS Biol, 3: e76.
        doi: 10.1371/journal.pbio.0030076

    2. Bayer P, Kraft M, Ejchart A, et al. 1995, Structural Studies of HIV-1 Tat Protein. J MoL Biol, 247:529-535.

    3. Brigati C, Giacca M, Noonan D M, et al. 2003, HIV Tat, its targets and the control of viral gene expression. FEMS Microbiol Lett, 220: 57-65.
        doi: 10.1016/S0378-1097(03)00067-3

    4. Brinkmann U, Mattes R E, Buckel P. 1989, High-level expression of recombinant genes in Escherichia coli is dependent on the availability of the dnaY gene product. Gene, 85: 109-114.
        doi: 10.1016/0378-1119(89)90470-8

    5. Brorson J R, Manzolillo P A, Gibbons S J, et al. 1995, AMPA receptor desensitization predicts the selective vulnerability of cerebellar Purkinje cells to excitotoxicity. J Neurosci, 15: 4515-4524.

    6. Chen G T, Inouye M. 1994, Role of the AGA/AGG codons, the rarest codons in global gene expression in Escherichia coli. Genes Dev. 8: 2641-2652.
        doi: 10.1101/gad.8.21.2641

    7. Dayton A I, Sodroski J G, Rosen C A, et al. 1986, The trans-activator gene of the human T cell lymphotropic virus type Ⅲ is required for replication.Cell, 44: 941-947.
        doi: 10.1016/0092-8674(86)90017-6

    8. Del Tito B J Jr, Ward J M, Hodgson J, et al. 1995, Effects of a Minor Isoleucyl tRNA on Heterologous Protein Translation in Escherichia coli. J Bacteriol, 177: 7086-7091.
        doi: 10.1128/jb.177.24.7086-7091.1995

    9. Dingwall C, Ernberg I, Gait M J, et al. 1989, Human immunodeficiency virus 1 tat protein binds trans-activation-responsive region (TAR) RNA in vitro. Proc Natl Acad Sci USA, 86: 6925-6929.
        doi: 10.1073/pnas.86.18.6925

    10. Ensoli B, Buonaguro L, Barillari G, et al. 1993, Release, uptake and effects of extracellular HIV-1 tat protein on cell growth in viral transactivation. J Virol, 67: 277-287.

    11. Frankel A D, Bredt D S, Pabo C O. 1988, Tat protein from human immunodeficiency virus forms a metal-linked dimmer. Science, 240: 70-73.
        doi: 10.1126/science.2832944

    12. Gaynor R. 1992, Cellular transcription factors involved in the regulation of HIV-1 gene expression. AIDS, 6: 347-363.
        doi: 10.1097/00002030-199204000-00001

    13. Gentz R, Chen C H, Rosen C A. 1989, Bioassay for trans-activation using purified human immunodeficiency virus tat-encoded protein: Trans-activation requires mRNA synthesis. Proc Natl Acad Sci USA, 86:821-824.
        doi: 10.1073/pnas.86.3.821

    14. http://www.emdbiosciences.com/docs/NDIS/inno12-001.pdf

    15. Kim S, Lee S B. 2006, Rare codon clusters at 5'-end influence heterologous expression of archaeal gene in Escherichia coli. Protein Expr Purif, 50: 49-57.
        doi: 10.1016/j.pep.2006.07.014

    16. Kirsch T, Boehm M, Schuckert O, et al. 1996, Cloning, High-Yield Expression in Escherichia coli, and Purification of Biologically Active HIV-1 Tat Protein. Protein Expr Purif, 8: 75-84.
        doi: 10.1006/prep.1996.0076

    17. Kleber-Janke T, Becker W M. 2000, Use of modified BL21(DE3) Escherichia coli cells for high-level expression of recombinant peanut allergens affected by poor codon usage. Protein Expr Purif, 19: 419-424.
        doi: 10.1006/prep.2000.1265

    18. Magnuson D S, Knudsen B E, Geiger J D, et al. 1995, Human immuno-deficiency virus type Ⅰ Tat activates non-N-methyl-d-aspartate excitatory aminoacid receptors and causes neurotoxicity. Ann Neurol, 37: 373-380.
        doi: 10.1002/(ISSN)1531-8249

    19. McKenna M C, Muchardt C, Gaynor R, et al. 1994, Preparative scale culture of Escherichia coli cells expressing the human immunodeficiency virus type 1 Tat protein. Protein Expr Purif, 5: 105-111.
        doi: 10.1006/prep.1994.1016

    20. Rice A P, Mathews M B. 1988, Transcriptional but not translational regulation of HIV-1 by the tat gene product. Nature, 332: 551-553.
        doi: 10.1038/332551a0

    21. Rosen C A, Sodroski J G, Haseltine W A. 1985, The location of cis-acting regulatory sequences in the human T cell lymphotropic virus type Ⅲ (HTLV-Ⅲ/LAV) long terminal repeat. Cell, 41: 813-823.
        doi: 10.1016/S0092-8674(85)80062-3

    22. Rosenberg A H, Goldman E, Dunn J J, et al. 1993, Effects of Consecutive AGG Codons on Translation in Escherichia coli, Demonstrated with a Versatile Codon Test System. J. Bacteriol, 175: 716-722.
        doi: 10.1128/jb.175.3.716-722.1993

    23. Ruben S, Perkins A, Purcell R, et al. 1989, Structural and functional characterization of human immunodeficiency virus tat protein. J. Virol, 63: 1-8.

    24. Rusnati M, Presta M. 2002, HIV-1 Tat protein and endothelium: from protein/cell interaction to AIDS-associated pathologies. Angiogenesis, 5: 141-151.
        doi: 10.1023/A:1023892223074

    25. Seidel H M, Pompliano D L, Knowles J R. 1992, Phosphonate biosynthesis: molecular cloning of the gene for phosphoenolpyruvate mutase from Tetrahymena pyriformis and overexpression of the gene product in Escherichia coli. Biochemistry, 31: 2598-2608.
        doi: 10.1021/bi00124a021

    26. Twyman R E, Gahring L C, Spiess J, et al. 1995, Glutamate receptor antibodies activate a subset of receptors and reveal an agonist binding site. Neuron, 14: 755-762.
        doi: 10.1016/0896-6273(95)90219-8

    27. Zdanovsky A G, Zdanovskaia M V. 2000, Simple and Efficient Method for Heterologous Expression of Clostridial Proteins. Appl Environ Microbiol, 66: 3166-3173.
        doi: 10.1128/AEM.66.8.3166-3173.2000

  • 加载中

Figures(5) / Tables(2)

Article Metrics

Article views(7831) PDF downloads(20) Cited by()

Related
Proportional views

    An Improved Strategy for Efficient Expression and Purification of Soluble HIV-1 Tat Protein in E.coli

      Corresponding author: Ping-kun ZHOU, zhoupk@nic.bmi.ac.cn
    • 1. The Department of Radiation Toxicology and Oncology, Beijing Institute of Radiation Medicine, Beijing 100850, China
    • 2. Institute of Microbiology and Epidemiology, Beijing 100071, China
    Fund Project:  a grant from the International Atomic Energy Agency (IAEA) 12510/R1a grant from the Chinese NationalNatural Science Foundation 30400120

    Abstract: Although the endogenous function of Tat has been elucidated in the past twenty years, the study of its exogenous activity has been hampered due to the difficulty of large scale preparation of the active Tat protein. To express the full-length Tat protein in E.coli, the tat gene was cloned from an HIV infected patient by overlapping PCR. Rare codon usage analysis showed that rare E.coli codons, especially consecutive rare codons for Arg, account for 14% (14 of 101) rare E.coli codons in the tat gene. The expression of the HIV-1 tat gene was verified to be very poor in strain BL21 (DE3) due to the abundance of rare codons; however, tat gene expression was found to be very efficient in the host strain of Rosetta-gami B (DE3), which was supplemented with six rare tRNAs for Arg, Leu, Ile and Pro. Subsequent purification revealed that the proteins are soluble and unusually, the tagged Tat can form dimers independent of cystine disulfide bonds. The purity, integrity and molecular weight of the Tat protein were demonstrated by MALDI-TOF mass spectrometry. Reporter gene activating assay was further confirmed by investigating the transactivation activity of the recombinant Tat protein. Our improved strategy for efficient high level expression and purification of soluble Tat protein has paved the way to fully investigate its exogenous function.